EDMONTON, May 8 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) today announced that Robert Kirkman, M.D., President and Chief Executive Officer, is scheduled to present at the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference at 3:35pm CEST/9:35am EDT/6:35am PDT on Monday, May 14th in Monte Carlo, Monaco. The presentation is planned for a live webcast and can be accessed at: http://www.wsw.com/webcast/rrshq11/biom and at the Biomira website (http://www.biomira.com/). Biomira intends to make a recording of the webcast available on the Biomira website approximately one hour after completion of the presentation. The presentation will be archived for 90 days. About Biomira Biomira is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Biomira's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. DATASOURCE: Biomira Inc. CONTACT: Investor and Media Relations Contact: Stephanie H. Seiler, Ph.D., Gemini BioProjects LLC, (206) 713-0124,

Copyright

Biomira Inc. - Common Shares (MM) (NASDAQ:BIOM)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas Biomira Inc. - Common Shares (MM).
Biomira Inc. - Common Shares (MM) (NASDAQ:BIOM)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas Biomira Inc. - Common Shares (MM).